Risks
4 risks
Risk Intelligence
Supply chain disruptions from geopolitical tensions
View Risks →
Bharat Electronics Limited — Q1 FY26
BEL reported Q1 FY26 revenue of INR 4,417 crore (+5.19% YoY), missing internal double-digit targets due to ~INR 200 crore revenue deferral from Israel-Iran supply chain disruptions.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
BEL reported Q1 FY26 revenue of INR 4,417 crore (+5.19% YoY), missing internal double-digit targets due to ~INR 200 crore revenue deferral from Israel-Iran supply chain disruptions. PAT grew 24.87% to INR 969 crore, while EBITDA margin expanded to 29.86% (+704bps YoY) driven by favorable product mix and indigenization. Order book stood at INR 74,859 crore as of July 1, with additional INR 2,600 crore received post-quarter. Management maintained FY26 guidance: revenue growth >15%, EBITDA margin >27%, order inflow INR 27,000+ crore (ex-QRSAM), and exports $120+ million. Key near-term catalysts include QRSAM order (expected Q4), emergency procurement orders, and LCA Mark 1A follow-on. Risk: supply chain disruptions from geopolitical tensions could delay execution.
BEL ने पहली तिमाही (अप्रैल-जून 2025) में 4,417 करोड़ रुपये की कमाई की, जो पिछले साल से 5.19% ज़्यादा है। लेकिन यह कंपनी के 10% से अधिक बढ़ोतरी के लक्ष्य से कम है, क्योंकि ईरान-इज़राइल विवाद के कारण करीब 200 करोड़ रुपये का ऑर्डर आने में देरी हुई। मुनाफा 24.87% बढ़कर 969 करोड़ रुपये हो गया। कंपनी की कमाई पर खर्च का अनुपात (EBITDA मार्जिन) 29.86% रहा, जो पिछले साल से 7% ज़्यादा है। इसकी वजह है सस्ते और देसी उत्पादों पर ज़ोर। 1 जुलाई तक कंपनी के पास 74,859 करोड़ रुपये के ऑर्डर थे, और तिमाही खत्म होने के बाद 2,600 करोड़ रुपये के नए ऑर्डर मिले। प्रबंधन ने पूरे साल के लिए लक्ष्य दोहराया: कमाई में 15% से अधिक बढ़ोतरी, मार्जिन 27% से ऊपर, और 27,000 करोड़ रुपये से अधिक के नए ऑर्डर। आने वाले समय में QRSAM ऑर्डर, आपात खरीद और LCA Mark 1A जैसे बड़े ऑर्डर मिल सकते हैं। लेकिन भू-राजनीतिक तनाव से आपूर्ति में रुकावट का खतरा बना हुआ है।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Order Book
INR 74,859 crore
+INR 2,600 crore post-quarter
Order book as of July 1, 2025, with additional orders received after quarter end.
Order Inflow Guidance
INR 27,000+ crore
Excluding QRSAM
FY26 order inflow target, with QRSAM potentially adding INR 30,000+ crore.
Export Guidance
$120+ million
20% YoY growth target
Export revenue target for FY26, with consistent 20% year-on-year growth.
R&D Investment
INR 1,600+ crore
6-7% of turnover
FY26 R&D spend commitment, focused on AI/ML and new technologies.
What Changed vs Last Quarter
UPDATED
Revenue growth >15% for FY26
Management reiterated revenue growth guidance of more than 15% for FY26, despite Q1 shortfall due to supply chain issues.
UPDATED
EBITDA margin >27% for FY26
Management maintained EBITDA margin guidance of more than 27% for the full year, with Q1 margin at 29.86%.
UPDATED
Order inflow INR 27,000+ crore (ex-QRSAM) for FY26
Order inflow target of INR 27,000+ crore for FY26, excluding QRSAM; if QRSAM comes in Q4, total could exceed INR 30,000 crore.
UPDATED
Capex of INR 1,000+ crore for FY26
Capital expenditure guidance of INR 1,000+ crore for FY26, driven by expansion and new test equipment.
NEW RISK
Supply chain disruptions from geopolitical tensions
Q1 revenue was impacted by ~INR 200 crore due to Israel-Iran conflict affecting component supplies; similar disruptions could recur.
NEW RISK
Dependence on nomination-based orders
Approximately 90% of order book is nomination-based; any shift to competitive bidding could pressure margins and win rates.
NEW RISK
Execution risk for large programs like QRSAM
QRSAM order expected in Q4 but may slip to next year; delays in RFP issuance could impact order inflow guidance.
NEW RISK
Employee cost pressure from pay revision
Eighth Pay Commission and PSU pay revision could increase employee costs from FY2028, though management expects growth to offset.
RISK GONE
QRSAM order slippage
The INR 30,000 crore QRSAM order may slip to Q1 FY27 due to procedural delays, impacting order inflow guidance.
RISK GONE
Margin pressure from faster execution
Faster execution of emergency procurement could pressure margins, though management expects indigenization to offset.
RISK GONE
Working capital deterioration
Operating cash flow dropped sharply to INR 586 crore in FY25 from INR 4,600 crore in FY24, partly due to order spillover.
RISK GONE
Export conversion delays
Export leads from recent conflict may take 1-2 years to convert into orders, delaying revenue recognition.
🤫 Topics management stopped discussing
Mentioned in Q1 FY25, Q3 FY25, Q4 FY25
The INR 30,000 crore QRSAM order may slip to Q1 FY27 due to procedural delays, impacting order inflow guidance.
Mentioned in Q1 FY25, Q3 FY25
A provision of ~₹600 crore was made for liquidated damages due to supply delays, indicating execution risks.
Fast read
Guidance and risk preview
Management reiterated revenue growth guidance of more than 15% for FY26, despite Q1 shortfall due to supply chain issues.
Q1 revenue was impacted by ~INR 200 crore due to Israel-Iran conflict affecting component supplies; similar disruptions could recur.
View Risks →